Abstract 6063: Genomic characterization of non-small cell lung cancer (NSCLC) brain metastasis (BM) patients identifies novel alterations associated with tropisms and disease progression

Henry Walch(Memorial Sloan Kettering Cancer Center), Luke Pike(Memorial Sloan Kettering Cancer Center), Brandon S. Imber(Memorial Sloan Kettering Cancer Center), Kenny Yu(Memorial Sloan Kettering Cancer Center), Pedram Razavi(Memorial Sloan Kettering Cancer Center), Yao Yu, Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Bob T. Li(Memorial Sloan Kettering Cancer Center), Atif J. Khan(Memorial Sloan Kettering Cancer Center), Daniel R. Gomez(Cedars-Sinai Medical Center), Simon N. Powell(Memorial Sloan Kettering Cancer Center), Kathryn R. Tringale(University of California, San Diego), Anna Skakodub(Icahn School of Medicine at Mount Sinai), Jorge S. Reis‐Filho(AstraZeneca (France)), Harish N. Vasudevan(Neurological Surgery), Nelson S. Moss(Memorial Sloan Kettering Cancer Center), Daniel W. Kelly(Memorial Sloan Kettering Cancer Center), Emily S. Lebow(University of Pennsylvania), Boris Mueller(Memorial Sloan Kettering Cancer Center), Jordan Eichholz(Memorial Sloan Kettering Cancer Center)

Cancer Research

April 4, 2023

Cited by 0

|Nature|2014|6.6k

|Nature Genetics|2019|4.4k

|Cell|2015|3.6k

|JCO Precision Oncology|2017|2.7k

|New England Journal of Medicine|2021|1.8k

Related Papers